Search

Search results

374 results found

Manganese intoxication and chronic liver failure. Ann Neurol 1994;36:871-875.

Publication: Journal Article

Hauser, RA, TA Zesiewicz, AS Rosemurgy, C Martinez, and CW Olanow. 1994. “Manganese Intoxication and Chronic Liver Failure. Ann Neurol 1994;36:871-875.”. Ann Neurol.

Critical drug appraisal. Pergolide. Drug Therapy 1990;20;62-71.

Publication: Journal Article

Hauser, RA, and CW Olanow. 1990. “Critical Drug Appraisal. Pergolide. Drug Therapy 1990;20;62-71.”. Drug Therapy.

Kelly Hussey, MPAS, PA-C

Person: Sub-Investigator, Physician Assistant

Kelly graduated with a Master’s degree in Physician Assistant Studies from the University Of Florida College Of Medicine. She is excited to be a member of the team at the USF Parkinson’s Disease and Movement Disorders Center. She has been working with Dr. Hauser at USF since 2012 and is the sub...

Evelyn Spiller, BS

Person: Clinical Research Associate, Study Coordinator

Evelyn Spiller holds a Bachelor of Science degree in Public Health and Infectious Disease. She has amassed two and a half years of research experience, encompassing trials in Infectious Disease, General Surgery, and a year and a half focused on Neurology. Currently, she coordinates four Randomized...

Contact Us

Page

for the P2B Study Group. Double-Blind Study comparing P2B001 (combination of low-doses of extended-release Pramipexole and Rasagiline) to components and to optimised doses of Pramipexole-extended release in early Parkinson’s Disease.

Publication: Journal Article

Hauser, RA, CW Olanow, D Burdick, R Dhall, JA de Marcaida, RA Gil, DL Kreitzman, L Elmer, A McGarry, and K Kieburtz. 2024. “For the P2B Study Group. Double-Blind Study Comparing P2B001 (combination of Low-Doses of Extended-Release Pramipexole and Rasagiline) to Components and to Optimised Doses of Pramipexole-Extended Release in Early Parkinson’s Disease.”. . Mov Disord. 2024 Feb;39(2):350-359. Doi: 10.1002/Mds.29642. Epub 2023 Oct 27. PMID: 37886872.

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.

Publication: Journal Article

Fung, VSC, J Aldred, MP Arroyo, F Bergquist, RA Hauser, M Bouchard, S Bray, et al. 2024. “Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion for the Treatment of Motor Fluctuations in Parkinson’s Disease: Considerations for Initiation and Maintenance.”. . Clin Park Relat Disord. 2024 Feb 10;10:100239. Doi: 10.1016/J.prdoa.2024.100239. ECollection 2024. PMID: 38419617.

OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2.

Publication: Journal Article

Hauser, RA, A Videnovic, P Soares-da-Silva, GS Liang, K Olson, E Jen, JF Rocha, and O Klepitskaya. 2024. “OFF-Times Before, During, and After Nighttime Sleep Periods in Parkinson’s Disease Patients With Motor Fluctuations and the Effects of Opicapone: A Post Hoc Analysis of Diary Data from BIPARK-1 and -2.”. Parkinsonism Relat Disord. 2024 Jun;123:106971. Doi: 10.1016/J.Parkreldis.2024.106971. Epub 2024 Apr 9.PMID: 38631081 .